LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,007 Cr | ₹1,663 Cr | ₹1,580 Cr | ₹1,354 Cr | ₹1,306 Cr |
What is the latest Sundry Debtors ratio of LAURUS LABS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,007 Cr |
| Mar2024 | ₹1,663 Cr |
| Mar2023 | ₹1,580 Cr |
| Mar2022 | ₹1,354 Cr |
| Mar2021 | ₹1,306 Cr |
How is Sundry Debtors of LAURUS LABS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,007 Cr | 20.70 | |
| Mar2024 | ₹1,663 Cr | 5.22 | |
| Mar2023 | ₹1,580 Cr | 16.71 | |
| Mar2022 | ₹1,354 Cr | 3.68 | |
| Mar2021 | ₹1,306 Cr | - | |
Compare Sundry Debtors of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹71,507.1 Cr | 4.6% | 18.6% | 121.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 4.6% |
18.6% |
121.9% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses